Ad is loading...
HLEZX
Price
$19.26
Change
-$0.16 (-0.82%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

HLEZX vs RNWFX

Header iconHLEZX vs RNWFX Comparison
Open Charts HLEZX vs RNWFXBanner chart's image
Harding Loevner Instl Emerg Mkts Z
Price$19.26
Change-$0.16 (-0.82%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
HLEZX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HLEZX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLEZX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. HLEZX (626M). RNWFX (1.51) and HLEZX (1.44) have matching dividends . HLEZX was incepted earlier than RNWFX: HLEZX (11 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. HLEZX (27.00). RNWFX has a lower initial minimum investment than HLEZX: RNWFX (250) vs HLEZX (5000000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. HLEZX (8.33). RNWFX return over 5 years is better than : 17.17 vs. HLEZX (-6.83).
HLEZXRNWFXHLEZX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD4.2777.09960%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets626M60.9B1%
Annual Yield % from dividends1.441.5195%
Returns for 1 year8.3311.5472%
Returns for 3 years-24.09-14.55166%
Returns for 5 years-6.8317.17-40%
Returns for 10 years15.1041.0037%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics